US Dollar (USD) could rise further to 153.65; the major resistance at 154.30 is unlikely to come under threat. In the longer ...

Royalty Pharma to provide R&D investment of up to $250 million for Biogen's litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment of lupus. NEW ...

The designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...

Valuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

In this webinar, panelists will draw upon lessons from around the world about how civil society groups can protect and promote democracy and the rule of law during episodes of democratic backsliding.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.